Anti-inflammatory multipurpose female vagina foaming agent

A foam, vaginal technology, used in anti-inflammatory agents, non-central analgesics, sexually transmitted diseases, etc., can solve the problems of delaying the disease, recurrent inflammation, inability to reduce inflammation and sterilization, and achieve the effect of eliminating symptoms and promoting reproduction.

Pending Publication Date: 2020-09-04
福州弘海生物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, most common gynecological inflammations such as vaginitis and cervicitis are treated with anti-inflammatory treatment or flora adjustment treatment alone; most of the gynecological products that are used for anti-inflammatory treatment alone are antibiotics, and long-term use is easy to produce Drug resistance, and destroy the balance of normal flora in women's vagina, leading to recurrent inflammation, difficult to cure
Bacteria adjustment therapy alone cannot quickly sterilize the existing inflammation, and the onset of effect is slow, which is easy to delay the disease and make it worse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] A multi-purpose female vaginal foam for anti-inflammation, which includes the following components in parts by weight:

[0024] 12 parts of chlorhexidine acetate;

[0025] Coconut oil fatty acid diethanolamide 170 parts;

[0026] 180 parts of triethanolamine;

[0027] Compound egg yolk antibody 15 parts;

[0028] Amphotericin B 6 parts;

[0029] Chitosan 10 parts;

[0030] Houttuynia cordata extract 120 parts;

[0031] 150 parts of zedoary oil;

[0032] 50 parts of matrine agent;

[0033] 3000 parts of deionized water.

[0034] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0035] Further, it also includes the following components by weight: 7 parts of metronidazole; 5 parts of clotrimazole. Metronidazole, clotrimazole, and chlorhexidine acetate foams have the advanta...

Embodiment 2

[0042] The present invention provides an anti-inflammatory multi-purpose vaginal foam for women, which comprises the following components in parts by weight:

[0043] 7.5 parts of chlorhexidine acetate;

[0044] Coconut oil fatty acid diethanolamide 160 parts;

[0045] 100 parts of triethanolamine;

[0046] Compound egg yolk antibody 6.5 parts;

[0047] Amphotericin B 2.4 parts;

[0048] Chitosan 7 parts;

[0049] Houttuynia cordata extract 70 parts;

[0050] Curcuma oil 50 parts;

[0051] 305 parts of matrine agent;

[0052] 500 parts of deionized water.

[0053] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0054] Further, it also includes the following components in parts by weight: 6.5 parts of metronidazole; 4.5 parts of clotrimazole. Metronidazole, clotrimazole, and c...

Embodiment 3

[0059] A multi-purpose female vaginal foam for anti-inflammation, which includes the following components in parts by weight:

[0060] 22.5 parts of chlorhexidine acetate;

[0061] Coconut oil fatty acid diethanolamide 180 parts;

[0062] 250 parts of triethanolamine;

[0063] Compound egg yolk antibody 25 copies;

[0064] Amphotericin B 8.6 parts;

[0065] Chitosan 15 parts;

[0066] Houttuynia cordata extract 200 parts;

[0067] Curcuma oil 200 parts;

[0068] 75 parts of matrine agent;

[0069] 6000 parts of deionized water.

[0070] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0071] Further, it also includes the following components in parts by weight: 8 parts of metronidazole; 6.5 parts of clotrimazole. Metronidazole, clotrimazole, and chlorhexidine acetate foams hav...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an anti-inflammatory multipurpose female vaginal foaming agent which comprises chlorhexidine acetate, coconutt diethanol amide, triethanolamine, composite egg yolk antibody, amphotericin B, chitosan, a cordate houttuynia extracting solution, zedoary turmeric oil, a matrine agent and deionized water. The composition comprises composite egg yolk antibody as an active component, and six pathogenic bacteria in the vagina can be killed and the environment in the vagina can be adjusted, so that the pH of the vagina is recovered and kept in a faintly acid state, propagation ofdominant bacteria such as lactic acid bacteria is promoted, and gynecologic inflammatory diseases such as vaginitis and cervicitis are effectively prevented or treatment from the angle of flora adjustment. Various anti-inflammatory and bactericidal drugs are adopted and matched with herba houttuyniae extract and other Chinese herbal medicine lotions to clean, disinfect and sterilize the interiorof the vagina, and flora adjustment is matched for sterilization and disinfection, so that diseases are eliminated in a short time.

Description

technical field [0001] The invention is applied to the field of vaginal anti-inflammation, in particular to a multi-purpose female vaginal foaming agent for anti-inflammation. Background technique [0002] Gynecological inflammation is a common disease in gynecological clinics. Among them, vaginitis and cervicitis are common gynecological inflammatory diseases. Their onset is mostly related to the imbalance of vaginal microecology in patients, and the treatment effect is poor and the recurrence rate is high. The main pathological change of vaginitis and cervicitis is the imbalance of vaginal flora, that is, the imbalance of microecological flora that normally parasitizes in the vagina, the reduction of beneficial bacteria such as Lactobacillus in the vagina and the proliferation of other bacteria, and the proliferation of anaerobic bacteria at the same time. Amines are produced, which alkalize the vagina, increase vaginal discharge and produce odor. Therefore, the key to pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/395A61K9/12A61P15/00A61P15/02A61P29/00A61P31/02A61K31/155A61K31/4164A61K31/4174A61K31/7048A61K36/78
CPCA61K39/395A61K31/4164A61K31/4174A61K31/155A61K31/7048A61K36/78A61K36/489A61K9/12A61K9/0034A61K47/44A61K47/36A61P15/02A61P15/00A61P31/02A61P29/00
Inventor 林理
Owner 福州弘海生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products